Clinical Trial Update: Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating two premedication regimens (methylprednisolone vs dexamethasone-based) to prevent systemic and injection-site reactions…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Motixafortide (motixafortide)

Snippet

Sponsor: Emory University | Conditions: Multiple Myeloma | Phase 4 | Status: RECRUITING